Overcoming the Global Health Threat of Antibiotic-Resistant Bacteria
Updated: Nov 21, 2018
IPS and IMS Presenting at the Military Health Research Symposium
Integrated Pharma Services (IPS) and Integrated MicroSciences (IMS) are dedicated to tackling the most pressing biomedical problem health care professionals face world-wide; Our Team is finding alternative ways to handle antibiotic resistant bacteria. Before Sir Alexander Fleming began the antibiotic revolution in 1928, infectious diseases were responsible for high morbidity and mortality worldwide. Bacterial meningitis, for example, took the lives of 90% of the children it infected. The surviving 10% of children had severe and lasting disabilities such as deafness and mental retardation. The antibiotic revolution greatly rose the life expectancy in the U.S. going from 47 years before antibiotics to 78.8 years currently.
Antibiotic resistant bacteria, such as Methicillin-Resistant Staphylococcus aureus (MRSA), pose a threatening global health problem affecting at least 2 million people according to the Centers for Diseases Control and Prevention (CDC). It is of critical importance that we come up with novel and effective strategies to treat patients suffering from antibiotic resistant infections.
Our team will be presenting 4 posters at the Military Health System Research Symposium (MHSRS) in Kissimmee Florida August 20—23. We will share the innovative work of our scientists for testing and developing new technologies and therapeutics against antibiotic resistance pathogens.
The poster titles being presented are:
Isolation and Antimicrobial Efficacy Testing of Propionibacterium acnes and MRSA Specific Bacteriophages
Antimicrobial Efficacy Testing of a Biomodulator Technology
Antimicrobial Efficacy Testing of a Novel Natural Antimicrobial Product
Antimicrobial Application of an Immunomodulating Drug
To learn about how we can support your product development Contact Dr. Mina Izadjoo
Email: email@example.com Phone 301-204-4201